Device Trial Radar · NCT01526811
Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
180
Actual
Start
Mar 2012
Primary completion
Dec 21, 2018
Study completion Dec 21, 2018
Sponsor
- Lead sponsor
- MedtronicPublic (MDT)
- Sponsor type
- Industry
- First posted
- Feb 6, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the benefits of endovascular repair with Endurant Stent Graft System by documenting overall mortality, complications, the rate of conversion to open surgical repair, and the development and rupture of the aneurysm on a long term, i.e. at 5 years, in a cohort of patients representative of the population treated under real-life conditions of use in France.
Conditions
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Vascular Diseases
- Cardiovascular Diseases
- Aortic Diseases
Interventions
Endurant Stent graftDevice
Endurant Stent graft implantation
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause mortalityTime frame: through 5 years
6 more outcomes with a free account
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Centre Hospitalier d'Avignon
Avignon, France
19 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.